Menu
Back to Browse Journals » Infection and Drug Resistance
Infection and Drug Resistance
- View all (237)
- Volume 10, 2017 (27)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- 237 records -
Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
Hsieh NH, Lin YJ, Yang YF, Liao CM
Infection and Drug Resistance 2017, 10:215-226
Published Date: 20 July 2017
Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia
Assefa D, Seyoum B, Oljira L
Infection and Drug Resistance 2017, 10:209-213
Published Date: 11 July 2017
Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B
Pacheco SR, Santos MIMA, Stocker A, Zarife MAS, Schinoni MI, Paraná R, Reis MG, Silva LK
Infection and Drug Resistance 2017, 10:201-207
Published Date: 5 July 2017
Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
Chong Y, Shimoda S, Miyake N, Aoki T, Ito Y, Kamimura T, Shimono N
Infection and Drug Resistance 2017, 10:193-199
Published Date: 27 June 2017
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B
Infection and Drug Resistance 2017, 10:185-192
Published Date: 14 June 2017
Prevalence and antibiotic resistance of coagulase-negative Staphylococci isolated from poultry farms in three regions of Ghana
Boamah VE, Agyare C, Odoi H, Adu F, Gbedema SY, Dalsgaard A
Infection and Drug Resistance 2017, 10:175-183
Published Date: 13 June 2017
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
Jaksuwan R, Tharavichikul P, Patumanond J, Chuchottaworn C, Chanwong S, Smithtikarn S, Settakorn J
Infection and Drug Resistance 2017, 10:167-174
Published Date: 10 June 2017
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Sarma S, Upadhyay S
Infection and Drug Resistance 2017, 10:155-165
Published Date: 7 June 2017
Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic
Carlson JM, Leonard AB, Hyde ER, Petrosino JF, Primm TP
Infection and Drug Resistance 2017, 10:143-154
Published Date: 9 May 2017
Uniform-related infection control practices of dental students
Aljohani Y, Almutadares M, Alfaifi K, El Madhoun M, Albahiti MH, Al-Hazmi N
Infection and Drug Resistance 2017, 10:135-142
Published Date: 24 April 2017
Drug resistance in influenza A virus: the epidemiology and management
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M
Infection and Drug Resistance 2017, 10:121-134
Published Date: 20 April 2017
Usefulness of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify pathogens, including polymicrobial samples, directly from blood culture broths
Hariu M, Watanabe Y, Oikawa N, Seki M
Infection and Drug Resistance 2017, 10:115-120
Published Date: 19 April 2017
In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil
Freitas LS, Almeida NCC, Freitas Queiroz MA, Zaninotto MM, Fuzii HT, Ribeiro-Silva A, Vallinoto ACR, Ishak MOG, Quaresma JAS, Ishak R
Infection and Drug Resistance 2017, 10:109-114
Published Date: 10 April 2017
The "black evil" affecting patients with diabetes: a case of rhino orbito cerebral mucormycosis causing Garcin syndrome
Narayanan S, Panarkandy G, Subramaniam G, Radhakrishnan C, Thulaseedharan NK, Manikath N, Ramaswamy S, Radhakrishnan S, Ekkalayil D
Infection and Drug Resistance 2017, 10:103-108
Published Date: 28 March 2017
Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India
Harichandran D, Dinesh KR
Infection and Drug Resistance 2017, 10:97-101
Published Date: 14 March 2017
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study
Workicho A, Kassahun W, Alemseged F
Infection and Drug Resistance 2017, 10:91-96
Published Date: 13 March 2017
Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru
Boehnke KF, Valdivieso M, Bussalleu A, Sexton R, Thompson KC, Osorio S, Novoa Reyes I, Crowley JJ, Baker LH, Xi C
Infection and Drug Resistance 2017, 10:85-90
Published Date: 10 March 2017
Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia
Brhane M, Kebede A, Petros Y
Infection and Drug Resistance 2017, 10:75-83
Published Date: 9 March 2017
Effect of a small molecule Lipid II binder on bacterial cell wall stress
Malin J, Shetty AC, Daugherty SC, de Leeuw EPH
Infection and Drug Resistance 2017, 10:69-73
Published Date: 28 February 2017
Post-influenza aspergillosis, do not underestimate influenza B
Nulens EF, Bourgeois MJ, Reynders MB
Infection and Drug Resistance 2017, 10:61-67
Published Date: 21 February 2017
Cerebral malaria: insight into pathogenesis, complications and molecular biomarkers
Yusuf FH, Hafiz MY, Shoaib M, Ahmed SA
Infection and Drug Resistance 2017, 10:57-59
Published Date: 2 February 2017
Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia
Althaqafi AO, Matar MJ, Moghnieh R, Alothman AF, Alenazi TH, Farahat F, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM
Infection and Drug Resistance 2017, 10:49-55
Published Date: 2 February 2017
Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia
Matar MJ, Moghnieh R, Alothman AF, Althaqafi AO, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM
Infection and Drug Resistance 2017, 10:43-48
Published Date: 3 February 2017
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon
Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM
Infection and Drug Resistance 2017, 10:35-41
Published Date: 2 February 2017
Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children
Legese MH, Weldearegay GM, Asrat D
Infection and Drug Resistance 2017, 10:27-34
Published Date: 25 January 2017
Occurrence of extended-spectrum and AmpC β-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria
Akinyemi KO, Iwalokun BA, Oyefolu AOB, Fakorede CO
Infection and Drug Resistance 2017, 10:19-25
Published Date: 13 January 2017
Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar’i N, Al-Balas Q
Infection and Drug Resistance 2017, 10:1-17
Published Date: 29 December 2016
A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
Sallam MM, Abou-Aisha K, El-Azizi M
Infection and Drug Resistance 2016, 9:301-311
Published Date: 8 December 2016
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
Natesan SK, Chandrasekar PH
Infection and Drug Resistance 2016, 9:291-300
Published Date: 7 December 2016
Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis
Lau CSM, Ward A, Chamberlain RS
Infection and Drug Resistance 2016, 9:275-289
Published Date: 7 December 2016
Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians
Spiekerman KM, Patel SJ, Patel R, Kociolek LK
Infection and Drug Resistance 2016, 9:269-274
Published Date: 5 December 2016
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
Vreden SGS, Bansie RD, Jitan JK, Adhin MR
Infection and Drug Resistance 2016, 9:261-267
Published Date: 24 November 2016
The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A
Infection and Drug Resistance 2016, 9:253-260
Published Date: 22 November 2016
Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience
Hirano R, Sakamoto Y, Kitazawa J, Yamamoto S, Tachibana N
Infection and Drug Resistance 2016, 9:243-252
Published Date: 14 October 2016
Evaluating vancomycin susceptibility in Staphylococcus aureus
Mimica MJ, Navarini A
Infection and Drug Resistance 2016, 9:239-241
Published Date: 26 September 2016
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
Burgel PR, Paugam A, Hubert D, Martin C
Infection and Drug Resistance 2016, 9:229-238
Published Date: 20 September 2016
Lemierre’s syndrome: current perspectives on diagnosis and management
Johannesen KM, Bodtger U
Infection and Drug Resistance 2016, 9:221-227
Published Date: 14 September 2016
Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
Stricker RB, Johnson L
Infection and Drug Resistance 2016, 9:215-219
Published Date: 13 September 2016
Peramivir injection in the treatment of acute influenza: a review of the literature
Wester A, Shetty AK
Infection and Drug Resistance 2016, 9:201-214
Published Date: 22 August 2016
Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:199-200
Published Date: 23 August 2016
Pelvic inflammatory disease: improving awareness, prevention, and treatment
Das BB, Ronda J, Trent M
Infection and Drug Resistance 2016, 9:191-197
Published Date: 19 August 2016
Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro
El-Azizi M, Khardori N
Infection and Drug Resistance 2016, 9:181-189
Published Date: 19 August 2016
Early detection of neonatal group B streptococcus sepsis and the possible diagnostic utility of IL-6, IL-8, and CD11b in a human umbilical cord blood in vitro model
Nakstad B, Sonerud T, Solevåg AL
Infection and Drug Resistance 2016, 9:171-179
Published Date: 8 July 2016
Strategies for prevention of ultrasound-guided prostate biopsy infections
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:161-169
Published Date: 8 July 2016
Emerging resistant serotypes of invasive Streptococcus pneumoniae
Elshafie S, Taj-Aldeen SJ
Infection and Drug Resistance 2016, 9:153-160
Published Date: 29 June 2016
Concern over Zika virus outbreak: another alarming global threat
Hafiz MY, Mahmood SU, Shoaib M, Yusuf FH
Infection and Drug Resistance 2016, 9:149-151
Published Date: 28 June 2016
An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes
Thabit AK, Nicolau DP
Infection and Drug Resistance 2016, 9:143-148
Published Date: 27 June 2016
Optimal management of genital herpes: current perspectives
Sauerbrei A
Infection and Drug Resistance 2016, 9:129-141
Published Date: 13 June 2016
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
Jones TM, Johnson SW, DiMondi VP, Wilson DT
Infection and Drug Resistance 2016, 9:119-128
Published Date: 7 June 2016
Conceptual framework for outcomes research studies of hepatitis C: an analytical review
Sbarigia U, Denee TR, Turner NG, Wan GJ, Morrison A, Kaufman AS, Rice G, Dusheiko GM
Infection and Drug Resistance 2016, 9:101-117
Published Date: 27 May 2016
Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients
Yuhashi K, Yagihara Y, Misawa Y, Sato T, Saito R, Okugawa S, Moriya K
Infection and Drug Resistance 2016, 9:93-99
Published Date: 27 May 2016
Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
Phillips CJ, Wells NA, Martinello M, Smith S, Woodman RJ, Gordon DL
Infection and Drug Resistance 2016, 9:87-92
Published Date: 31 May 2016
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
Donnelley MA, Zhu ES, Thompson GR 3rd
Infection and Drug Resistance 2016, 9:79-86
Published Date: 2 June 2016
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
Watters CM, Burton T, Kirui DK, Millenbaugh NJ
Infection and Drug Resistance 2016, 9:71-78
Published Date: 27 April 2016
Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
Hawkshead III JJ, Van Dyke RB, Hassig SE, Webber LS, Begue RE
Infection and Drug Resistance 2016, 9:59-70
Published Date: 18 April 2016
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Gonzalez-Ruiz A, Seaton RA, Hamed K
Infection and Drug Resistance 2016, 9:47-58
Published Date: 15 April 2016
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Rustomjee R, Zumla A
Infection and Drug Resistance 2016, 9:43-45
Published Date: 1 April 2016
Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature
Chipolombwe J, Török ME, Mbelle N, Nyasulu P
Infection and Drug Resistance 2016, 9:35-42
Published Date: 12 February 2016
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus
Potashman MH, Stokes M, Liu J, Lawrence R, Harris L
Infection and Drug Resistance 2016, 9:19-33
Published Date: 28 January 2016
Pseudomonas aeruginosa ventilator-associated pneumonia management
Ramírez-Estrada S, Borgatta B, Rello J
Infection and Drug Resistance 2016, 9:7-18
Published Date: 20 January 2016
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
Gupta AK, Daigle D
Infection and Drug Resistance 2016, 9:1-6
Published Date: 18 January 2016
Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana
Opintan JA, Newman MJ, Arhin RE, Donkor ES, Gyansa-Lutterodt M, Mills-Pappoe W
Infection and Drug Resistance 2015, 8:379-389
Published Date: 18 November 2015
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
Brigden G, Hewison C, Varaine F
Infection and Drug Resistance 2015, 8:367-378
Published Date: 30 October 2015
Delamanid expanded access novel treatment of drug resistant tuberculosis
Rustomjee R, Zumla A
Infection and Drug Resistance 2015, 8:359-366
Published Date: 29 October 2015
Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection
Hagiya H, Tasaka K, Sendo T, Otsuka F
Infection and Drug Resistance 2015, 8:353-357
Published Date: 20 October 2015
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Taha H, Das A, Das S
Infection and Drug Resistance 2015, 8:339-352
Published Date: 1 October 2015
Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm
Crowther GS, Wilcox MH
Infection and Drug Resistance 2015, 8:333-337
Published Date: 15 September 2015
Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
Soysal A
Infection and Drug Resistance 2015, 8:321-331
Published Date: 9 September 2015
Modeling human influenza infection in the laboratory
Radigan KA, Misharin AV, Chi M, Scott Budinger GR
Infection and Drug Resistance 2015, 8:311-320
Published Date: 31 August 2015
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
Zmarlicka MT, Nailor MD, Nicolau DP
Infection and Drug Resistance 2015, 8:297-309
Published Date: 24 August 2015
Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria
Russotto V, Cortegiani A, Graziano G, Saporito L, Raineri SM, Mammina C, Giarratano A
Infection and Drug Resistance 2015, 8:287-296
Published Date: 10 August 2015
Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
Al Alawi S, Abdulkarim S, Elhennawy H, Al-Mansoor A, Al Ansari A
Infection and Drug Resistance 2015, 8:279-285
Published Date: 7 August 2015
Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus
Melendez DP, Razonable RR
Infection and Drug Resistance 2015, 8:269-277
Published Date: 5 August 2015
Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections
Shaikh SBU, Ahmed Z, Arsalan SA, Shafiq S
Infection and Drug Resistance 2015, 8:263-267
Published Date: 31 July 2015
Impact of space flight on bacterial virulence and antibiotic susceptibility
Taylor PW
Infection and Drug Resistance 2015, 8:249-262
Published Date: 30 July 2015
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs
Malone JG
Infection and Drug Resistance 2015, 8:237-247
Published Date: 29 July 2015
Profile and microbiological isolates of asymptomatic bacteriuria among pregnant women in Abakaliki, Nigeria
Onu FA, Ajah LO, Ezeonu PO, Umeora OUJ, Ibekwe PC, Ajah MI
Infection and Drug Resistance 2015, 8:231-235
Published Date: 24 July 2015
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
O’Driscoll T, Crank CW
Infection and Drug Resistance 2015, 8:217-230
Published Date: 24 July 2015
Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand
Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Tantraworasin A
Infection and Drug Resistance 2015, 8:207-216
Published Date: 16 July 2015
Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience
Hirano R, Sakamoto Y, Kudo K, Ohnishi M
Infection and Drug Resistance 2015, 8:199-205
Published Date: 8 July 2015
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections
Mitra S, Saeed U, Havlichek DH, Stein GE
Infection and Drug Resistance 2015, 8:189-197
Published Date: 6 July 2015
Histopathological changes induced in an animal model by potentially pathogenic Enterococcus faecalis strains recovered from ready-to-eat food outlets in Osun State, Nigeria
Olawale AK, David OM, Oluyege AO, Osuntoyinbo RT, Laleye SA, Famurewa O
Infection and Drug Resistance 2015, 8:181-187
Published Date: 26 June 2015
Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates
El Houfi A, Javed N, Solem CT, Macahilig C, Stephens JM, Raghubir N, Chambers R, Li JZ, Haider S
Infection and Drug Resistance 2015, 8:173-179
Published Date: 18 June 2015
Efinaconazole in the treatment of onychomycosis
Lipner SR, Scher RK
Infection and Drug Resistance 2015, 8:163-172
Published Date: 1 June 2015
Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations
Couldwell DL, Lewis DA
Infection and Drug Resistance 2015, 8:147-161
Published Date: 26 May 2015
Corynebacterium urealyticum: a comprehensive review of an understated organism
Salem N, Salem L, Saber S, Ismail G, Bluth MH
Infection and Drug Resistance 2015, 8:129-145
Published Date: 21 May 2015
Chronic Lyme disease: misconceptions and challenges for patient management
Halperin JJ
Infection and Drug Resistance 2015, 8:119-128
Published Date: 15 May 2015
Polymerase chain reaction-based active surveillance of MRSA in emergency department patients
Seki M, Takahashi H, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Ogura H, Shimazu T, Tomono K
Infection and Drug Resistance 2015, 8:113-118
Published Date: 14 May 2015
Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital
Takahashi H, Seki M, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Toyokawa M, Nishi I, Ogura H, Shimazu T, Tomono K
Infection and Drug Resistance 2015, 8:107-111
Published Date: 14 May 2015
blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria
Akinyemi KO, Iwalokun BA, Alafe OO, Mudashiru SA, Fakorede C
Infection and Drug Resistance 2015, 8:99-106
Published Date: 11 May 2015
Current trends in the prevalence of Cryptococcus gattii in the United States and Canada
Espinel-Ingroff A, Kidd SE
Infection and Drug Resistance 2015, 8:89-97
Published Date: 11 May 2015
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis
AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, Talaq E, Abu-Madi M, Fotedar R
Infection and Drug Resistance 2015, 8:83-88
Published Date: 30 April 2015
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Hall RG 2nd, Michaels HN
Infection and Drug Resistance 2015, 8:75-82
Published Date: 22 April 2015
Influence of host resistance on viral adaptation: hepatitis C virus as a case study
Plauzolles A, Lucas M, Gaudieri S
Infection and Drug Resistance 2015, 8:63-74
Published Date: 7 April 2015
Agriculture and food animals as a source of antimicrobial-resistant bacteria
Economou V, Gousia P
Infection and Drug Resistance 2015, 8:49-61
Published Date: 1 April 2015
Lymphogranuloma venereum: diagnostic and treatment challenges
Ceovic R, Jerkovic Gulin S
Infection and Drug Resistance 2015, 8:39-47
Published Date: 27 March 2015
Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital
Kabbara WK, Nawas GT, Ramadan WH
Infection and Drug Resistance 2015, 8:31-38
Published Date: 24 March 2015
The role of dolutegravir in the management of HIV infections
Miller MM, Liedtke MD, Lockhart SM, Rathbun RC
Infection and Drug Resistance 2015, 8:19-29
Published Date: 19 February 2015
The relationship between hand hygiene and health care-associated infection: it’s complicated
McLaws ML
Infection and Drug Resistance 2015, 8:7-18
Published Date: 29 January 2015
Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula
Nakayama T, Ueda S, Huong BTM, Tuyen LD, Komalamisra C, Kusolsuk T, Hirai I, Yamamoto Y
Infection and Drug Resistance 2015, 8:1-5
Published Date: 23 January 2015
Antibiotic lock therapy: review of technique and logistical challenges
Justo JA, Bookstaver PB
Infection and Drug Resistance 2014, 7:343-363
Published Date: 12 December 2014
Current perspectives on the spread of dengue in India
Gupta E, Ballani N
Infection and Drug Resistance 2014, 7:337-342
Published Date: 11 December 2014
Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates?
Yoshida J, Harada Y, Kikuchi T, Asano I, Ueno T, Matsubara N
Infection and Drug Resistance 2014, 7:331-335
Published Date: 1 December 2014
The effect of a unique propolis compound (PropoelixTM) on clinical outcomes in patients with dengue hemorrhagic fever
Soroy L, Bagus S, Yongkie IP, Djoko W
Infection and Drug Resistance 2014, 7:323-329
Published Date: 9 December 2014
Virulence and antimicrobial resistance of Escherichia coli isolated from Tigris River and children diarrhea
Ibrahim IA, Al-Shwaikh RM, Ismaeil MI
Infection and Drug Resistance 2014, 7:317-322
Published Date: 26 November 2014
Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
AbdulWahab A, Taj-Aldeen SJ, Ibrahim E, Abdulla SH, Muhammed R, Ahmed I, Abdeen Y, Sadek O, Abu-Madi M
Infection and Drug Resistance 2014, 7:309-316
Published Date: 20 November 2014
Nosocomial bacteriuria in elderly inpatients may be leading to considerable antibiotic overuse: an audit of current management practice in a secondary level care hospital in New Zealand
Blakiston M, Zaman S
Infection and Drug Resistance 2014, 7:301-308
Published Date: 13 November 2014
Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy
Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA, Chandra P
Infection and Drug Resistance 2014, 7:289-299
Published Date: 6 November 2014
Middle East respiratory syndrome coronavirus: epidemiology and disease control measures
Al-Tawfiq JA, Memish ZA
Infection and Drug Resistance 2014, 7:281-287
Published Date: 3 November 2014
An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C
Infection and Drug Resistance 2014, 7:273-280
Published Date: 24 October 2014
Optimizing antimicrobial therapy in critically ill patients
Vitrat V, Hautefeuille S, Janssen C, Bougon D, Sirodot M, Pagani L
Infection and Drug Resistance 2014, 7:261-271
Published Date: 20 October 2014
Genotypes and phenotypes of Shiga toxin-producing Escherichia coli (STEC) in Abeokuta, Southwestern Nigeria
Olowe OA, Aboderin BW, Idris OO, Mabayoje VO, Opaleye OO, Adekunle OC, Olowe RA, Akinduti PA, Ojurongbe O
Infection and Drug Resistance 2014, 7:253-259
Published Date: 15 October 2014
Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity
Steiner DJ, Furuya Y, Metzger DW
Infection and Drug Resistance 2014, 7:239-251
Published Date: 18 September 2014
Peptidomimetics as a new generation of antimicrobial agents: current progress
Méndez-Samperio P
Infection and Drug Resistance 2014, 7:229-237
Published Date: 30 August 2014
Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis
Dookie N, Sturm AW, Moodley P
Infection and Drug Resistance 2014, 7:223-228
Published Date: 19 August 2014
E. coli O157 outbreaks in the United Kingdom: past, present, and future
Pennington TH
Infection and Drug Resistance 2014, 7:211-222
Published Date: 19 August 2014
Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit
Chittawatanarat K, Jaipakdee W, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T
Infection and Drug Resistance 2014, 7:203-210
Published Date: 16 August 2014
Comparative analysis of the infectivity rate of both Borrelia burgdorferi and Anaplasma phagocytophilum in humans and dogs in a New Jersey community
Gaito A, Gjivoje V, Lutz S, Baxter B
Infection and Drug Resistance 2014, 7:199-201
Published Date: 7 August 2014
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, Chidiac C, Ader F, Ferry T
Infection and Drug Resistance 2014, 7:183-197
Published Date: 5 July 2014
Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M
Infection and Drug Resistance 2014, 7:177-182
Published Date: 27 June 2014
Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
Huddleston JR
Infection and Drug Resistance 2014, 7:167-176
Published Date: 20 June 2014
Epidemiology and disease burden of tuberculosis in children: a global perspective
Seddon JA, Shingadia D
Infection and Drug Resistance 2014, 7:153-165
Published Date: 18 June 2014
Importance of antimicrobial stewardship to the English National Health Service
Dixon J, Duncan CJA
Infection and Drug Resistance 2014, 7:145-152
Published Date: 30 May 2014
Corticosteroids in the treatment of dengue shock syndrome
Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC
Infection and Drug Resistance 2014, 7:137-143
Published Date: 22 May 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Rubinstein E, Stryjewski ME, Barriere SL
Infection and Drug Resistance 2014, 7:129-135
Published Date: 20 May 2014
Staphylococcus aureus – antimicrobial resistance and the immunocompromised child
McNeil JC
Infection and Drug Resistance 2014, 7:117-127
Published Date: 7 May 2014
Gold mining areas in Suriname: reservoirs of malaria resistance?
Adhin MR, Labadie-Bracho M, Vreden S
Infection and Drug Resistance 2014, 7:111-116
Published Date: 5 May 2014
Raxibacumab: potential role in the treatment of inhalational anthrax
Kummerfeldt CE
Infection and Drug Resistance 2014, 7:101-109
Published Date: 29 April 2014
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
Hedari CP, Khinkarly RW, Dbaibo GS
Infection and Drug Resistance 2014, 7:85-99
Published Date: 3 April 2014
Long-term efficacy and safety of raltegravir in the management of HIV infection
Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC
Infection and Drug Resistance 2014, 7:73-84
Published Date: 18 March 2014
Community-acquired Clostridium difficile infection: an increasing public health threat
Gupta A, Khanna S
Infection and Drug Resistance 2014, 7:63-72
Published Date: 17 March 2014
Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
Leistner R, Sakellariou C, Gürntke S, Kola A, Steinmetz I, Kohler C, Pfeifer Y, Eller C, Gastmeier P, Schwab F
Infection and Drug Resistance 2014, 7:57-62
Published Date: 13 March 2014
Approaches to hepatitis C treatment and cure using NS5A inhibitors
Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF
Infection and Drug Resistance 2014, 7:41-56
Published Date: 5 March 2014
A case of bacteremia caused by Campylobacter fetus: an unusual presentation in an infant
Alnimr AM
Infection and Drug Resistance 2014, 7:37-40
Published Date: 25 February 2014
Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections
Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL
Infection and Drug Resistance 2014, 7:25-35
Published Date: 18 February 2014
Update on otitis media – prevention and treatment
Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M
Infection and Drug Resistance 2014, 7:15-24
Published Date: 10 January 2014
Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
Saidel-Odes L, Borer A
Infection and Drug Resistance 2014, 7:9-14
Published Date: 10 December 2013
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
Wilke M, Grube R
Infection and Drug Resistance 2014, 7:1-7
Published Date: 18 December 2013
The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae
Miossec C, Claudon M, Levasseur P, Black MT
Infection and Drug Resistance 2013, 6:235-240
Published Date: 3 December 2013
Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria
Onoh RC, Umeora OUJ, Egwuatu VE, Ezeonu PO, Onoh TJP
Infection and Drug Resistance 2013, 6:225-233
Published Date: 2 December 2013
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
Hong MC, Hsu DI, Bounthavong M
Infection and Drug Resistance 2013, 6:215-223
Published Date: 29 November 2013
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco
Zakham F, Chaoui I, Echchaoui AH, Chetioui F, Elmessaoudi MD, Ennaji MM, Abid M, El Mzibri M
Infection and Drug Resistance 2013, 6:207-213
Published Date: 28 November 2013
Prevalence of nontyphoidal Salmonella serogroups and their antimicrobial resistance patterns in a university teaching hospital in Eastern Province of Saudi Arabia
Elhadi N, Aljindan R, Aljeldah M
Infection and Drug Resistance 2013, 6:199-205
Published Date: 22 November 2013
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
Kamali A, Holodniy M
Infection and Drug Resistance 2013, 6:187-198
Published Date: 19 November 2013
Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus
Antonic V, Stojadinovic A, Zhang B, Izadjoo MJ, Alavi M
Infection and Drug Resistance 2013, 6:175-186
Published Date: 6 November 2013
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
Falci DR, Pasqualotto AC
Infection and Drug Resistance 2013, 6:163-174
Published Date: 22 October 2013
Management strategies in the treatment of neonatal and pediatric gastroenteritis
Ciccarelli S, Stolfi I, Caramia G
Infection and Drug Resistance 2013, 6:133-161
Published Date: 29 October 2013
Communicable disease-related sudden death in the 21st century in Nigeria
Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA
Infection and Drug Resistance 2013, 6:125-132
Published Date: 7 October 2013
Whole-genome sequencing in bacteriology: state of the art
Dark MJ
Infection and Drug Resistance 2013, 6:115-123
Published Date: 8 October 2013
The use of platensimycin and platencin to fight antibiotic resistance
Allahverdiyev AM, Bagirova M, Abamor ES, Ates SC, Koc RC, Miraloglu M, Elcicek S, Yaman S, Unal G
Infection and Drug Resistance 2013, 6:99-114
Published Date: 18 September 2013
Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden
Tham J, Odenholt I, Walder M, Andersson L, Melander E
Infection and Drug Resistance 2013, 6:93-97
Published Date: 19 September 2013
Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria
Olowe OA, Kukoyi OO, Taiwo SS, Ojurongbe O, Opaleye OO, Bolaji OS, Adegoke AA, Makanjuola OB, Ogbolu DO, Alli OT
Infection and Drug Resistance 2013, 6:87-92
Published Date: 20 August 2013
Procalcitonin as a useful marker to decide upon intervention for urinary tract infection
Sugimoto K, Shimizu N, Matsumura N, Oki T, Nose K, Nishioka T, Uemura H
Infection and Drug Resistance 2013, 6:83-86
Published Date: 7 August 2013
Streptococcus group C meningitis with cavernous sinus thrombosis
Clarke M, Enuh H, Saverimuttu J, Nfonoyim J
Infection and Drug Resistance 2013, 6:79-81
Published Date: 7 August 2013
Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana
Donkor ES, Foster-Nyarko E, Enweronu-Laryea CC
Infection and Drug Resistance 2013, 6:71-77
Published Date: 29 July 2013
Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan
Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, Yamamoto A, Yamamoto M, Toyoshima H, Kawakami F, Matsuura N, Yamamoto Y
Infection and Drug Resistance 2013, 6:67-70
Published Date: 22 July 2013
Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcus aureus surveillance: a 60-month study
Yoshida J, Kikuchi T, Matsubara N, Asano I, Ogami N
Infection and Drug Resistance 2013, 6:59-66
Published Date: 23 July 2013
Asymptomatic bacteriuria among elderly and middle-aged rural community-dwellers in South-Western Nigeria
Olowe OA, Makanjuola OB, Olabiyi KO, Akinwusi PO, Alebiosu CO, Isawumi MA, Hassan MB, Asekun-Olarinmoye EO, Adebimpe WO, Adewole TA
Infection and Drug Resistance 2013, 6:55-58
Published Date: 9 July 2013
Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
Chaparro-Rojas F, Mullane KM
Infection and Drug Resistance 2013, 6:41-53
Published Date: 28 June 2013
Invasive Aspergillus infections in hospitalized patients with chronic lung disease
Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR
Infection and Drug Resistance 2013, 6:33-39
Published Date: 27 May 2013
In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide
Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI
Infection and Drug Resistance 2013, 6:27-32
Published Date: 6 March 2013
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Wissing H, Ballus J, Bingold TM, Nocea G, Krobot KJ, Kaskel P, Kumar RN, Mavros P
Infection and Drug Resistance 2013, 6:15-25
Published Date: 30 January 2013
Update on the management of chronic rhinosinusitis
Cain RB, Lal D
Infection and Drug Resistance 2013, 6:1-14
Published Date: 23 January 2013
Current management options for latent tuberculosis: a review
Norton BL, Holland DP
Infection and Drug Resistance 2012, 5:163-173
Published Date: 29 November 2012
Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period
Hughes A, Davies L, Hale R, Gallagher JE
Infection and Drug Resistance 2012, 5:155-161
Published Date: 25 October 2012
Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes
Marí Solivellas B, Cabanes Martín T
Infection and Drug Resistance 2012, 5:149-153
Published Date: 16 October 2012
Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
Tham J, Walder M, Melander E, Odenholt I
Infection and Drug Resistance 2012, 5:143-147
Published Date: 16 October 2012
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
Chen LF, Anderson DJ, Paterson DL
Infection and Drug Resistance 2012, 5:133-141
Published Date: 24 September 2012
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T
Infection and Drug Resistance 2012, 5:129-132
Published Date: 22 August 2012
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Falsey AR
Infection and Drug Resistance 2012, 5:121-127
Published Date: 8 August 2012
Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005
Ako BA, Offianan AT, Johansson M, Penali LK, Nguetta SP, Sibley CH
Infection and Drug Resistance 2012, 5:113-120
Published Date: 1 August 2012
Treatment of dengue fever
Rajapakse S, Rodrigo C, Rajapakse A
Infection and Drug Resistance 2012, 5:103-112
Published Date: 23 July 2012
Clinical update on linezolid in the treatment of Gram-positive bacterial infections
Ager S, Gould K
Infection and Drug Resistance 2012, 5:87-102
Published Date: 25 June 2012
Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, Mitarai S, Yamada N
Infection and Drug Resistance 2012, 5:79-86
Published Date: 7 May 2012
The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study
Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM
Infection and Drug Resistance 2012, 5:75-78
Published Date: 24 April 2012
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Stålsby Lundborg C
Infection and Drug Resistance 2012, 5:65-73
Published Date: 5 April 2012
Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire
Offianan AT, Penali LK, Coulibaly MA, Tiacoh NL, Ako AAB, Adji EG, Coulibaly B, Koffi D, Sarr D, Jambou R, Kone M
Infection and Drug Resistance 2012, 5:53-63
Published Date: 12 March 2012
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI
Infection and Drug Resistance 2012, 5:43-51
Published Date: 1 February 2012
Conjunctival sac bacterial flora isolated prior to cataract surgery
Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H
Infection and Drug Resistance 2012, 5:37-41
Published Date: 24 January 2012
Ceftaroline in complicated skin and skin-structure infections
Hernandez PO, Lema S, Tyring SK, Mendoza N
Infection and Drug Resistance 2012, 5:23-35
Published Date: 19 January 2012
Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M
Infection and Drug Resistance 2012, 5:17-21
Published Date: 13 January 2012
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
Miceli MH, Chandrasekar P
Infection and Drug Resistance 2012, 5:9-16
Published Date: 11 January 2012
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Thaiss WM, Thaiss CC, Thaiss CA
Infection and Drug Resistance 2012, 5:1-8
Published Date: 9 January 2012
A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae
Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M
Infection and Drug Resistance 2011, 4:221-224
Published Date: 15 December 2011
Resistance to antimicrobial drugs in Ghana
Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A
Infection and Drug Resistance 2011, 4:215-220
Published Date: 21 December 2011
An Enterobacter plasmid as a new genetic background for the transposon Tn1331
Alavi MR, Antonic V, Ravizee A, Weina PJ, Izadjoo M, Stojadinovic A
Infection and Drug Resistance 2011, 4:209-213
Published Date: 28 November 2011
Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public
Nguyen T, Holdt Henningsen K, Brehaut JC, Hoe E, Wilson K
Infection and Drug Resistance 2011, 4:197-207
Published Date: 20 October 2011
Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, Murakami A
Infection and Drug Resistance 2011, 4:191-196
Published Date: 20 October 2011
Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy
Bush LM, Chaparro-Rojas F, Okeh V, Etienne J
Infection and Drug Resistance 2011, 4:177-189
Published Date: 18 October 2011
Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran
Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N
Infection and Drug Resistance 2011, 4:171-176
Published Date: 11 October 2011
Meningococcal conjugate vaccines: optimizing global impact
Terranella A, Cohn A, Clark T
Infection and Drug Resistance 2011, 4:161-169
Published Date: 21 September 2011
Review of oral cholera vaccines: efficacy in young children
Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN
Infection and Drug Resistance 2011, 4:155-160
Published Date: 14 September 2011
Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital
Oliveira PR, Paula AP, Dal-Paz K, Felix CS, Rossi F, Silva JS, Lima ALM
Infection and Drug Resistance 2011, 4:149-154
Published Date: 4 August 2011
Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease
Bröker M, Cooper B, DeTora LM, Stoddard JJ
Infection and Drug Resistance 2011, 4:137-147
Published Date: 22 July 2011
Treatment of drug-resistant tuberculosis
Pinto LM, Menzies D
Infection and Drug Resistance 2011, 4:129-135
Published Date: 21 July 2011
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
White B, Seaton RA
Infection and Drug Resistance 2011, 4:115-127
Published Date: 24 May 2011
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB
Infection and Drug Resistance 2011, 4:97-113
Published Date: 3 May 2011
Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
Lida Jafari Saraf, Samuel Eric Wilson
Infection and Drug Resistance 2011, 4:87-95
Published Date: 10 March 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
Mary L Townsend, Melanie W Pound, Richard H Drew
Infection and Drug Resistance 2011, 4:77-86
Published Date: 2 March 2011
Patterns of resistance development with integrase inhibitors in HIV
Jean L Mbisa, Supang A Martin, Patricia A Cane
Infection and Drug Resistance 2011, 4:65-76
Published Date: 22 February 2011
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
Melissa Osborn
Infection and Drug Resistance 2011, 4:55-64
Published Date: 3 February 2011
Update on the optimal use of voriconazole for invasive fungal infections
Asma Lat George R Thompson III
Infection and Drug Resistance 2011, 4:43-53
Published Date: 3 February 2011
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Roger Sordé, Albert Pahissa, Jordi Rello
Infection and Drug Resistance 2011, 4:31-41
Published Date: 25 January 2011
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges
Brandie D Taylor, Catherine L Haggerty
Infection and Drug Resistance 2011, 4:19-29
Published Date: 20 January 2011
Current treatment of choice for chronic hepatitis C infection
Tareq Yasin, Thomas R Riley, Ian R Schreibman
Infection and Drug Resistance 2011, 4:11-18
Published Date: 12 January 2011
Lyme disease: the next decade
Raphael B Stricker, Lorraine Johnson
Infection and Drug Resistance 2011, 4:1-9
Published Date: 7 January 2011
Current strategies for the prevention and management of central line-associated bloodstream infections
Zhuolin Han, Stephen Y Liang, Jonas Marschall
Infection and Drug Resistance 2010, 3:147-163
Published Date: 23 November 2010
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
Josep Quer, Maria Buti, Maria Cubero, et al
Infection and Drug Resistance 2010, 3:133-145
Published Date: 23 November 2010
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
Martha K Daddario, Jennifer K Hagerman, Michael E Klepser
Infection and Drug Resistance 2010, 3:123-132
Published Date: 28 October 2010
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al
Infection and Drug Resistance 2010, 3:115-122
Published Date: 22 October 2010
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
Charlotte Charpentier, Laurence Weiss
Infection and Drug Resistance 2010, 3:103-114
Published Date: 13 October 2010
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.
Infection and Drug Resistance 2010, 3:95-101
Published Date: 30 August 2010
Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al
Infection and Drug Resistance 2010, 3:87-94
Published Date: 19 August 2010
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Alicia I Hidron, Russell Kempker, Abeer Moanna, et al
Infection and Drug Resistance 2010, 3:73-86
Published Date: 6 August 2010
The use of anti-tuberculosis therapy for latent TB infection
Justin T Denholm, Emma S McBryde
Infection and Drug Resistance 2010, 3:63-72
Published Date: 21 July 2010
Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change
J Mebis, H Jansens, G Minalu, et al
Infection and Drug Resistance 2010, 3:53-61
Published Date: 28 July 2010
Role of posaconazole in the treatment of oropharyngeal candidiasis
Voichita Ianas, Kathryn R Matthias, Stephen A Klotz
Infection and Drug Resistance 2010, 3:45-51
Published Date: 28 June 2010
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
Lorenzo Aguilar, María-José Giménez, José Barberán
Infection and Drug Resistance 2010, 3:35-43
Published Date: 18 June 2010
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Whitney P Caron, Shaker A Mousa
Infection and Drug Resistance 2010, 3:25-33
Published Date: 21 May 2010
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
Lisa M Chirch, Roy T Steigbigel
Infection and Drug Resistance 2010, 3:15-23
Published Date: 26 April 2010
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
César Bustos, Jose L Del Pozo
Infection and Drug Resistance 2010, 3:5-14
Published Date: 22 April 2010
Respiratory failure caused by intrathoracic amoebiasis
Toshinobu Yokoyama, Masashi Hirokawa, Yutaka Imamura, et al
Infection and Drug Resistance 2010, 3:1-4
Published Date: 11 March 2010
Anidulafungin and its role in candida infections
Diane M Cappelletty, Rose Jung
Infection and Drug Resistance 2009, 2:51-60
Published Date: 30 June 2009
Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections
Tze Shien Lo, Stephanie M Borchardt, Justin M Welch, Melissa A Rohrich, Augusto M Alonto, Anne V Alonto
Infection and Drug Resistance 2009, 2:41-49
Published Date: 30 June 2009
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus
William J Peppard, Anne Daniels, Lynne Fehrenbacher, Jamie Winner
Infection and Drug Resistance 2009, 2:27-40
Published Date: 8 June 2009
New approaches in the management of chronic hepatitis B: role of tenofovir
Jurriën GP Reijnders, Harry LA Janssen
Infection and Drug Resistance 2009, 2:13-26
Published Date: 24 April 2009
The determinants of the antibiotic resistance process
Beatriz Espinosa Franco, Marina Altagracia Martínez, Martha A Sánchez Rodríguez, Albert I Wertheimer
Infection and Drug Resistance 2009, 2:1-11
Published Date: 17 April 2009
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
Nathan P Wiederhold, Jason M Cota, Christopher R Frei
Infection and Drug Resistance 2008, 1:63-77
Published Date: 12 January 2009
High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India
Hare Krishna Tiwari, Darshan Sapkota, Malaya Ranjan Sen
Infection and Drug Resistance 2008, 1:57-61
Published Date: 30 November 2008
Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
Somvadee Laohavaleeson, Karen Lolans, John P Quinn, Joseph L Kuti, David P Nicolau
Infection and Drug Resistance 2008, 1:51-55
Published Date: 23 November 2008
Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco
Hayat Ennaji, Mohammed Timinouni, My Mustapha Ennaji, Mohammed Hassar, Nozha Cohen
Infection and Drug Resistance 2008, 1:45-50
Published Date: 28 September 2008
Current and novel antibiotics against resistant Gram-positive bacteria
Federico Perez, Robert A Salata, Robert A Bonomo
Infection and Drug Resistance 2008, 1:27-44
Published Date: 9 September 2008
New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice
Nora Morcillo, Belén Imperiale, Juan Carlos Palomino
Infection and Drug Resistance 2008, 1:21-26
Published Date: 20 August 2008
Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children
Hafid Belhadj-Tahar, Yvon Coulais, Mathieu Tafani, François Bouissou
Infection and Drug Resistance 2008, 1:17-20
Published Date: 12 August 2008
Pilonidal sinus of the penis
H Al Chalabi, H A Ghalib, M Nabri, T O’Hanrahan
Infection and Drug Resistance 2008, 1:13-15
Published Date: 6 August 2008
Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
Christy A Beneri, David P Nicolau, Howard S Seiden, Lorry G Rubin
Infection and Drug Resistance 2008, 1:9-11
Published Date: 12 August 2008
Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics
Shih-Wei Yang, Ming-Hsun Lee, Lai-Chu See, Shu-Huan Huang, Tsung-Ming Chen, Tai-An Chen
Infection and Drug Resistance 2008, 1:1-8
Published Date: 7 July 2008